000			01714 a2200517 4500
005			20250515131711.0
264		0	_c20081208
008			200812s 0 0 eng d
022			_a1476-5594
024	7		_a10.1038/onc.2008.255 _2doi
040			_aNLM _beng _cNLM
100	1		_aTaniguchi, E
245	0	0	_aPDGFR-A is a therapeutic target in alveolar rhabdomyosarcoma. _h[electronic resource]
260			_bOncogene _cNov 2008
300			_a6550-60 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aBenzamides
650	0	4	_aCell Line, Tumor
650	0	4	_aCells, Cultured
650	0	4	_aGenes, p16
650	0	4	_aHumans
650	0	4	_aImatinib Mesylate
650	0	4	_aMice
650	0	4	_aMice, Knockout
650	0	4	_aMuscle Neoplasms _xdrug therapy
650	0	4	_aPiperazines _xtherapeutic use
650	0	4	_aProtein Kinase Inhibitors _xtherapeutic use
650	0	4	_aPyrimidines _xtherapeutic use
650	0	4	_aReceptor, Platelet-Derived Growth Factor alpha _xantagonists & inhibitors
650	0	4	_aRhabdomyosarcoma, Alveolar _xdrug therapy
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aNishijo, K
700	1		_aMcCleish, A T
700	1		_aMichalek, J E
700	1		_aGrayson, M H
700	1		_aInfante, A J
700	1		_aAbboud, H E
700	1		_aLegallo, R D
700	1		_aQualman, S J
700	1		_aRubin, B P
700	1		_aKeller, C
773	0		_tOncogene _gvol. 27 _gno. 51 _gp. 6550-60
856	4	0	_uhttps://doi.org/10.1038/onc.2008.255 _zAvailable from publisher's website
999			_c18154351 _d18154351